Back

A multi-centre audit on the impact of optimal guideline directed medical therapy (GDMT) on left ventricular ejection fraction (LVEF) in Irish heart failure nurse-led clinics.

13 May 2024 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - clinical 1 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Ms Jennifer Aherne

Cork University Hospital, Cork (Ireland)

7 More presentations in this session

Presentation thumbnail
Sex and gender differences in characteristics, treatment, and short-term prognosis among patients with acute myocarditis in Korea
Doctor M. Kim (Seoul, KR)
Abstract Slides
Presentation thumbnail
Impact of cardiac sarcoidosis on admissions for acute-on-chronic combined systolic and diastolic heart failure
Mr G. Yeap (GB)
Abstract Slides Video
Presentation thumbnail
The early evaluation of diuretic resistance as recommended by ESC Guidelines predicts long-term outcomes in patients with acute heart failure.
Mr J. Lopez Azor (Majadahonda, ES)
Abstract Slides Video
Presentation thumbnail
Congestion as a crucial factor determining albuminuria in in patients with cardiorenal disease
Doctor P. Llacer (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
The association between body mass index and right ventricular dysfunction in orthopedic trauma
Associate Professor H. Kim (Guri, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure - clinical 1

The Event

Event poster

Heart Failure 2024

13 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Improvement in left ventricular ejection fraction with quadruple therapy in patients with heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Scarred for life - outcomes of ischaemic and non-ischaemic cardiomyopathy after heart failure optimisation
thumbnail
Congress Presentation
First implementation results from the Trial for Evaluating Accelerated Guideline-Directed Medical Therapy for Heart Failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources